Matsushita, Shigeto <br/><br/>
p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells.  [electronic resource] 

 -  Journal of dermatological science  Oct 2012 
 - 19-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1873-569X 
<br/><br/><label>Standard No.: </label>10.1016/j.jdermsci.2012.07.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--pharmacology<br/>Cell Cycle Proteins--genetics<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Child<br/>Cisplatin--pharmacology<br/>Cyclin-Dependent Kinase Inhibitor p21--metabolism<br/>Dacarbazine--pharmacology<br/>Dose-Response Relationship, Drug<br/>Female<br/>Gene Expression Regulation, Enzymologic<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Melanoma--enzymology<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Neoplasm Staging<br/>Nimustine--pharmacology<br/>Prognosis<br/>RNA Interference<br/>Ribonucleotide Reductases--genetics<br/>Skin Neoplasms--enzymology<br/>Transfection<br/>Vincristine--pharmacology<br/>Young Adult